(Q54290180)

27 May 2018

title

A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation. (English)

1 reference

27 May 2018

0 references

M Greiner

1

1 reference

27 May 2018

A Cusini

2

1 reference

27 May 2018

M Ruesch

3

1 reference

27 May 2018

M Schiesser

4

1 reference

27 May 2018

B Ledergerber

5

1 reference

27 May 2018

T Fehr

6

1 reference

27 May 2018

N J Mueller

7

1 reference

27 May 2018

publication date

28 September 2012

1 reference

27 May 2018

published in

Infection

1 reference

27 May 2018

volume

40

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

669-675

1 reference

27 May 2018

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

Primary CMV infections are common in kidney transplant recipients after 6 months valganciclovir prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: a meta-analysis and systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

Universal prophylaxis is cost effective in cytomegalovirus serology-positive kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0343-5

Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23015480

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S15010-012-0343-5

1 reference

27 May 2018

1 reference

27 May 2018